These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22955482)

  • 1. Crohn ankylosis: a destructive elbow and wrist joint arthritis 2 decades following childhood abdominal pain.
    Mizelle KV; Scott WW; Gelber AC
    J Clin Rheumatol; 2012 Sep; 18(6):312-3. PubMed ID: 22955482
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful use of infliximab for treating fistulizing pouchitis with severe extraintestinal manifestation: a case report.
    Molnar T; Farkas K; Nagy F; Wittmann T
    Inflamm Bowel Dis; 2008 Dec; 14(12):1752-3. PubMed ID: 18452207
    [No Abstract]   [Full Text] [Related]  

  • 3. Favorable response to infliximab treatment in a patient with active Crohn disease and pyoderma gangrenosum.
    Triantafillidis JK; Cheracakis P; Sklavaina M; Apostolopoulou K
    Scand J Gastroenterol; 2002 Jul; 37(7):863-5. PubMed ID: 12190104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
    Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
    Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of infliximab in pyoderma gangrenosum.
    Hewitt D; Tait C
    Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyoderma gangrenosum associated with crohn disease: effect of TNF-alpha blockade with infliximab.
    Ljung T; Staun M; Grove O; Fausa O; Vatn MH; Hellström PM
    Scand J Gastroenterol; 2002 Sep; 37(9):1108-10. PubMed ID: 12374238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of severe peristomal pyoderma gangrenosum with infliximab in a child with Crohn disease.
    Batres LA; Mamula P; Baldassano RN
    J Pediatr Gastroenterol Nutr; 2002 May; 34(5):558-60. PubMed ID: 12050585
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases.
    Cocco A; Angelucci E; Viscido A; Caprilli R
    Inflamm Bowel Dis; 2007 Oct; 13(10):1317-9. PubMed ID: 17508417
    [No Abstract]   [Full Text] [Related]  

  • 9. Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody.
    Tan MH; Gordon M; Lebwohl O; George J; Lebwohl MG
    Arch Dermatol; 2001 Jul; 137(7):930-3. PubMed ID: 11453813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyoderma gangrenosum associated with inflammatory bowel disease. Report of two cases with good response to infliximab.
    Carrasco Cubero C; Ruiz Tudela MM; Salaberri Maestrojuan JJ; Pérez Venegas JJ
    Reumatol Clin; 2012; 8(2):90-2. PubMed ID: 22104047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab for peristomal pyoderma gangrenosum.
    Mimouni D; Anhalt GJ; Kouba DJ; Nousari HC
    Br J Dermatol; 2003 Apr; 148(4):813-6. PubMed ID: 12752145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auricular pyoderma gangrenosum associated with Crohn's disease.
    Ben Chaabane N; Hellara O; Ben Mansour W; Ben Mansour I; Melki W; Loghmeri H; Safer L; Bdioui F; Saffar H
    Tunis Med; 2012 May; 90(5):414-5. PubMed ID: 22585655
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of aseptic abscesses syndrome treated with corticosteroids and TNF-alpha blockade.
    Ito T; Sato N; Yamazaki H; Koike T; Emura I; Saeki T
    Mod Rheumatol; 2013 Jan; 23(1):195-9. PubMed ID: 22526827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab for treatment of resistant pyoderma gangrenosum associated with Crohn's disease.
    Ferkolj I; Hocevar A; Golouh R; Dolenc Voljc M
    Acta Dermatovenerol Alp Pannonica Adriat; 2006 Dec; 15(4):173-7. PubMed ID: 17982610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A woman with painful ulcera on her lower leg].
    Schreuder RM; Horváth B; van Dullemen HM
    Ned Tijdschr Geneeskd; 2015; 159():A8783. PubMed ID: 26131750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatologic manifestations of Crohn disease in children: response to infliximab.
    Kugathasan S; Miranda A; Nocton J; Drolet BA; Raasch C; Binion DG
    J Pediatr Gastroenterol Nutr; 2003 Aug; 37(2):150-4. PubMed ID: 12883301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroid-resistant pyoderma gangrenosum associated with Crohn's disease: rapid cure with infliximab.
    Grange F; Djilali-Bouzina F; Weiss AM; Polette A; Guillaume JC
    Dermatology; 2002; 205(3):278-80. PubMed ID: 12399677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis.
    Teich N; Klugmann T
    J Crohns Colitis; 2014 Jan; 8(1):85-6. PubMed ID: 23810275
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pyoderma gangrenosum in Crohn's disease].
    Baryshnikov EN; Neĭman KP
    Eksp Klin Gastroenterol; 2008; (5):92-4. PubMed ID: 19145923
    [No Abstract]   [Full Text] [Related]  

  • 20. Penile Crohn's disease resolved by infliximab.
    Lee Y; Lee YM; Kim MJ; Choe YH
    J Crohns Colitis; 2013 May; 7(4):e146-9. PubMed ID: 22841132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.